Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 32

1.

Aplastic anemia in the elderly: a nationwide survey on behalf of the French Reference Center for Aplastic Anemia.

Contejean A, Resche-Rigon M, Tamburini J, Alcantara M, Jardin F, Lengliné E, Adès L, Bouscary D, Marçais A, Lebon D, Chabrot C, Terriou L, Barraco F, Banos A, Bussot L, Cahn JY, Hirsch P, Maillard N, Simon L, Fornecker LM, Socié G, de Latour RP, de Fontbrune FS.

Haematologica. 2019 Feb;104(2):256-262. doi: 10.3324/haematol.2018.198440. Epub 2018 Sep 27.

2.

FLT3-TKD Mutations Associated With NPM1 Mutations Define a Favorable-risk Group in Patients With Acute Myeloid Leukemia.

Perry M, Bertoli S, Rocher C, Hayette S, Ducastelle S, Barraco F, Labussière-Wallet H, Salles G, Recher C, Thomas X, Paubelle E.

Clin Lymphoma Myeloma Leuk. 2018 Dec;18(12):e545-e550. doi: 10.1016/j.clml.2018.06.006. Epub 2018 Jun 13.

PMID:
30082225
3.

Elderly Patients (Age 70 Years or Older) With Secondary Acute Myeloid Leukemia or Acute Myeloid Leukemia Developed Concurrently to Another Malignant Disease.

Collinge E, Loron S, Larcher MV, Elhamri M, Heiblig M, Deloire A, Ducastelle S, Labussière H, Barraco F, Wattel E, Salles G, Paubelle E, Thomas X.

Clin Lymphoma Myeloma Leuk. 2018 May;18(5):e211-e218. doi: 10.1016/j.clml.2018.02.018. Epub 2018 Mar 2.

PMID:
29572159
4.

Nationwide survey on the use of horse antithymocyte globulins (ATGAM) in patients with acquired aplastic anemia: A report on behalf of the French Reference Center for Aplastic Anemia.

Peffault de Latour R, Tabrizi R, Marcais A, Leblanc T, Lamy T, Mohty M, Tavitian S, Jubert C, Pasquet M, Galambrun C, Nguyen S, Cahn JY, Braun T, Deconinck E, Bay JO, Sicre de Fontbrune F, Barraco F, Socié G.

Am J Hematol. 2018 May;93(5):635-642. doi: 10.1002/ajh.25050. Epub 2018 Feb 14.

PMID:
29377260
5.

Hematopoietic stem cell transplantation for patients with paroxysmal nocturnal hemoglobinuria previously treated with eculizumab: a retrospective study of 21 patients from SFGM-TC centers.

Vallet N, de Fontbrune FS, Loschi M, Desmier D, Villate A, Barraco F, Chevallier P, Terriou L, Yakoub-Agha I, Ruggeri A, Mohty M, Maillard N, Rohrlich PS, Ceballos P, Nguyen S, Poiré X, Guillerm G, Tabrizi R, Farhi J, Devillier R, Rubio MT, Socié G, de Latour RP; Société Francophone de Greffe de Moelle et Thérapie Cellulaire.

Haematologica. 2018 Mar;103(3):e103-e105. doi: 10.3324/haematol.2017.182360. Epub 2017 Dec 21. No abstract available.

6.

Extracorporeal photopheresis for GVHD prophylaxis after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation: a prospective multicenter phase 2 study.

Michallet M, Sobh M, Garban F, Bulabois CE, Yakoub-Agha I, Coiteux V, Dulery R, Rohrlich PS, Legrand F, Clement L, Praire A, Detrait M, Barraco F, Nicolini FE, Hequet O.

Leuk Lymphoma. 2018 Feb;59(2):372-380. doi: 10.1080/10428194.2017.1334120. Epub 2017 Jun 7.

PMID:
28587506
7.

Cerebrovascular events as presenting manifestations of Myeloproliferative Neoplasm.

Ong E, Barraco F, Nighoghossian N, Praire A, Desestret V, Derex L, Vighetto A, Biotti D.

Rev Neurol (Paris). 2016 Nov;172(11):703-708. doi: 10.1016/j.neurol.2016.09.010. Epub 2016 Oct 27.

PMID:
28241944
8.

Fractionated gemtuzumab ozogamicin combined with intermediate-dose cytarabine and daunorubicin as salvage therapy in very high-risk AML patients: a bridge to reduced intensity conditioning transplant?

Paubelle E, Ducastelle-Leprêtre S, Labussière-Wallet H, Nicolini FE, Barraco F, Plesa A, Salles G, Wattel E, Thomas X.

Ann Hematol. 2017 Mar;96(3):363-371. doi: 10.1007/s00277-016-2899-0. Epub 2016 Dec 23.

PMID:
28011984
9.

Potential anti-leukemic activity of iron chelation after allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia.

Michallet M, Sobh M, Labussière H, Lombard C, Barraco F, El-Hamri M, Thomas X, Chapuis-Cellier C, Nicolini FE.

Leuk Lymphoma. 2017 Jan;58(1):237-240. Epub 2016 May 31. No abstract available.

PMID:
27243275
10.

Actinomycosis after allogeneic hematopoietic stem cell transplantation despite penicillin prophylaxis.

Barraco F, Labussière-Wallet H, Valour F, Ducastelle-Leprêtre S, Nicolini FE, Thomas X, Ferry T, Dumitrescu O, Michallet M, Ader F; Lyon HEMINF Study Group.

Transpl Infect Dis. 2016 Aug;18(4):595-600. doi: 10.1111/tid.12549. Epub 2016 Jul 5.

PMID:
27203624
11.

Treatment patterns and comparative effectiveness in elderly acute myeloid leukemia patients (age 70 years or older): the Lyon-university hospital experience.

Heiblig M, Le Jeune C, Elhamri M, Balsat M, Tigaud I, Plesa A, Barraco F, Labussière H, Ducastelle S, Nicolini F, Wattel E, Salles G, Thomas X.

Leuk Lymphoma. 2017 Jan;58(1):110-117. Epub 2016 May 17.

PMID:
27184036
12.

A matched case-control study of toxoplasmosis after allogeneic haematopoietic stem cell transplantation: still a devastating complication.

Conrad A, Le Maréchal M, Dupont D, Ducastelle-Leprêtre S, Balsat M, Labussière-Wallet H, Barraco F, Nicolini FE, Thomas X, Gilis L, Chidiac C, Ferry T, Wallet F, Rabodonirina M, Salles G, Michallet M, Ader F; Lyon HEMINF study Group.

Clin Microbiol Infect. 2016 Jul;22(7):636-41. doi: 10.1016/j.cmi.2016.04.025. Epub 2016 May 10.

13.

Using EasyMatch® to anticipate the identification of an HLA identical unrelated donor: A validated efficient time and cost saving method.

Dubois V, Detrait M, Sobh M, Morisset S, Labussière H, Giannoli C, Nicolini F, Moskovtchenko P, Mialou V, Ducastelle S, Rey S, Thomas X, Barraco F, Tedone N, Marry E, Garnier F, Bertrand Y, Michallet M.

Hum Immunol. 2016 Nov;77(11):1008-1015. doi: 10.1016/j.humimm.2016.02.004. Epub 2016 Feb 20.

PMID:
26902994
14.

Treatment with Low-Dose Cytarabine in Elderly Patients (Age 70 Years or Older) with Acute Myeloid Leukemia: A Single Institution Experience.

Heiblig M, Elhamri M, Tigaud I, Plesa A, Barraco F, Labussière H, Ducastelle S, Michallet M, Nicolini F, Plesa C, Wattel E, Salles G, Thomas X.

Mediterr J Hematol Infect Dis. 2016 Jan 1;8(1):e2016009. doi: 10.4084/MJHID.2016.009. eCollection 2016.

15.

Cidofovir in the Treatment of BK Virus-Associated Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation.

Philippe M, Ranchon F, Gilis L, Schwiertz V, Vantard N, Ader F, Labussiere-Wallet H, Thomas X, Nicolini FE, Wattel E, Ducastelle-Leprêtre S, Barraco F, Lebras L, Salles G, Michallet M, Rioufol C.

Biol Blood Marrow Transplant. 2016 Apr;22(4):723-730. doi: 10.1016/j.bbmt.2015.12.009. Epub 2015 Dec 21.

16.

Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study.

Loschi M, Porcher R, Barraco F, Terriou L, Mohty M, de Guibert S, Mahe B, Lemal R, Dumas PY, Etienne G, Jardin F, Royer B, Bordessoule D, Rohrlich PS, Fornecker LM, Salanoubat C, Maury S, Cahn JY, Vincent L, Sene T, Rigaudeau S, Nguyen S, Lepretre AC, Mary JY, Corront B, Socie G, Peffault de Latour R.

Am J Hematol. 2016 Jun;91(4):366-70. doi: 10.1002/ajh.24278.

17.

HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patterns.

Quintela A, Escuret V, Roux S, Bonnafous P, Gilis L, Barraco F, Labussière-Wallet H, Duscastelle-Leprêtre S, Nicolini FE, Thomas X, Chidiac C, Ferry T, Frobert E, Morisset S, Poitevin-Later F, Monneret G, Michallet M, Ader F; Lyon HEMINF Study Group.

J Infect. 2016 Feb;72(2):214-22. doi: 10.1016/j.jinf.2015.09.039. Epub 2015 Oct 28.

PMID:
26518057
18.

Suggestive evidence of a role of HLA-DRB4 mismatches in the outcome of allogeneic hematopoietic stem cell transplantation with HLA-10/10-matched unrelated donors: a French-Swiss retrospective study.

Detrait M, Morisset S, Chalandon Y, Yakoub-Agha I, Dufossé F, Labalette M, Top I, Elsermans V, Barraco F, Quintela A, Tedone N, Michallet M, Raus N, Tiercy JM, Dubois V.

Bone Marrow Transplant. 2015 Oct;50(10):1316-20. doi: 10.1038/bmt.2015.157. Epub 2015 Jul 6.

PMID:
26146803
19.

Pre-transplantation risk factors to develop sclerotic chronic GvHD after allogeneic HSCT: a multicenter retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

Detrait MY, Morisset S, Peffault de Latour R, Yakoub-Agha I, Crocchiolo R, Tabrizi R, Bay JO, Chevalier P, Barraco F, Raus N, Vigouroux S, Magro L, Mohty M, Milpied N, Blaise D, Socié G, Michallet M.

Bone Marrow Transplant. 2015 Feb;50(2):253-8. doi: 10.1038/bmt.2014.244. Epub 2014 Nov 3.

PMID:
25365068
20.

Allogeneic hematopoietic stem cell transplant for hematological malignancies from mismatched 9/10 human leukocyte antigen unrelated donors: comparison with transplants from 10/10 unrelated donors and human leukocyte antigen identical siblings.

Michallet M, Sobh M, Serrier C, Morisset S, Labussière H, Ducastelle S, Barraco F, Gilis L, Thomas X, Nicolini FE.

Leuk Lymphoma. 2015 Apr;56(4):999-1003. doi: 10.3109/10428194.2014.944518. Epub 2014 Aug 20.

PMID:
25029640
21.

High burden of BK virus-associated hemorrhagic cystitis in patients undergoing allogeneic hematopoietic stem cell transplantation.

Gilis L, Morisset S, Billaud G, Ducastelle-Leprêtre S, Labussière-Wallet H, Nicolini FE, Barraco F, Detrait M, Thomas X, Tedone N, Sobh M, Chidiac C, Ferry T, Salles G, Michallet M, Ader F; Lyon BK virus Study group.

Bone Marrow Transplant. 2014 May;49(5):664-70. doi: 10.1038/bmt.2013.235. Epub 2014 Feb 3.

PMID:
24488049
22.

Prospective study of erythropoietin use on quality of life and cost effectiveness in acute myeloid leukemia and allogeneic hematopoietic stem cell transplantation patients.

Michallet M, Goldet K, Sobh M, Morisset S, Chelghoum Y, Thomas X, Barraco F, Ducastelle S, Labussière H, Renzullo C, Paillet C, Pivot C, Straaten PB, Denis A, Termoz A, Detrait M, Nicolini FE, Jaisson-Hot I.

Cancer. 2013 Jan 1;119(1):107-14. doi: 10.1002/cncr.27686. Epub 2012 Jun 28.

23.

Impact of anti-HLA antibodies on allogeneic hematopoietic stem cell transplantation outcomes after reduced-intensity conditioning regimens.

Detrait M, Dubois V, Sobh M, Morisset S, Tedone N, Labussière H, Gillis L, Barraco F, Cannas G, Ducastelle S, Fatoum J, Thomas X, Chelgoum Y, Nicolini FE, Michallet M.

Exp Hematol. 2012 Oct;40(10):792-9. doi: 10.1016/j.exphem.2012.06.003. Epub 2012 Jun 12.

PMID:
22705505
24.

Invasive aspergillosis: an important risk factor on the short- and long-term survival of acute myeloid leukemia (AML) patients.

Michallet M, Bénet T, Sobh M, Kraghel S, El Hamri M, Cannas G, Nicolini FE, Labussière H, Ducastelle S, Barraco F, Thomas X, Chelghoum Y, Nicolle MC, Bienvenu AL, Persat F, De Monbrison F, Picot S, Vanhems P.

Eur J Clin Microbiol Infect Dis. 2012 Jun;31(6):991-7. doi: 10.1007/s10096-011-1397-5. Epub 2011 Sep 10.

PMID:
21909650
25.

A single dose pegfilgrastim for supporting neutrophil recovery in patients treated for high-risk acute myeloid leukemia by the EMA 2000 schedule.

Derbel O, Cannas G, Le QH, Elhamri M, Chelghoum Y, Nicolas-Virelizier E, Nicolini F, Troncy J, Barraco F, Michallet M, Thomas X.

Hematology. 2010 Jun;15(3):125-31. doi: 10.1179/102453309X12583347113654.

PMID:
20557669
26.

The rationale and use of hypomethylation agents in adult acute myeloid leukemia.

Thomas X, Chelghoum Y, Barraco F, Troncy J.

Expert Opin Drug Discov. 2009 Feb;4(2):195-205. doi: 10.1517/17460440802707337.

PMID:
23480516
27.

Role of the pathologist in organ transplantation: the North Italy Transplant program experience.

Valente M, Calabrese F, Angelini A, Castiglione AG, Rigotti P, Ragani M, Torelli R, Barraco F, Rago C.

Transplant Proc. 2006 May;38(4):983-5.

PMID:
16757238
28.

[Renal transplantation in the North Italy Transplant program (NITp): Organ allocation and results].

Cardillo M, Barraco F, De Fazio N, Rossini G, Pizzi C, Boschiero L, Nocera A, Rigotti P, Marchini F, Sandrini S, Frova G, Chiaramonte S, Maresca C, Caldara R, Messa P, Berardinelli L, Ambrosini A, Montanaro D, Rampino T, Minetti E, Gotti E, Scalamogna M.

G Ital Nefrol. 2005 Jan-Feb;22 Suppl 31:S30-5. Italian.

PMID:
15786399
29.

Renal transplantation. Strategies to prevent organ rejection--the role of an inter-regional reference center.

Cardillo M, Poli F, Barraco F, De Fazio N, Rossini G, Boschiero L, Nocera A, Rigotti P, Marchini F, Zacchello G, Zanon G, Sandrini S, Chiaramonte S, Maresca C, Caldara R, Messa P, Berardinelli L, Ambrosini A, Montanaro D, Rampino T, Minetti E, Gotti E, Ghio L, Ginevri F, Albertario F, Scalamogna M.

Contrib Nephrol. 2005;146:1-10. Review.

PMID:
15567915
30.

Clinical and molecular aspects of 23 patients affected by paroxysmal nocturnal hemoglobinuria.

Boschetti C, Fermo E, Bianchi P, Vercellati C, Barraco F, Zanella A.

Am J Hematol. 2004 Sep;77(1):36-44.

31.

A case of complete adenylate kinase deficiency due to a nonsense mutation in AK-1 gene (Arg 107 --> Stop, CGA --> TGA) associated with chronic haemolytic anaemia.

Bianchi P, Zappa M, Bredi E, Vercellati C, Pelissero G, Barraco F, Zanella A.

Br J Haematol. 1999 Apr;105(1):75-9.

PMID:
10233365
32.

[A case of creolin poisoning].

Barraco F.

Minerva Anestesiol. 1983 Sep;49(9):531-4. Italian. No abstract available.

PMID:
6657088

Supplemental Content

Loading ...
Support Center